May 23, 2011 — Use of short- and long-acting inhaled anticholinergic medications (IACs) is associated with an increased risk for acute urinary retention (AUR) in men with chronic obstructive pulmonary ...
The use of inhaled anticholinergic agents (medications that help reduce bronchospasm) by patients with chronic obstructive pulmonary disease (COPD) is associated with a significantly increased risk of ...
WINSTON-SALEM, N.C. – New research out of Wake Forest University School of Medicine shows that use of the most commonly prescribed once-a-day treatment for chronic obstructive pulmonary disease (COPD) ...
NEW YORK (Reuters Health) - The long-term use of inhaled drugs, referred to as "anticholinergic," such as ipratropium and tiotropium, for chronic obstructive pulmonary disease may increase the risk of ...
The main goals of chronic obstructive pulmonary disease (COPD) management include treatment of symptoms and prevention of exacerbations. Current guidelines recommend use of one or more long-acting ...
Angiogram of an MI (left) and a normal coronary artery (right) Inhaled anticholinergic agents, the most common treatment for chronic obstructive pulmonary disease (COPD), may increase the risk of ...
The addition of multiple doses of inhaled ipratropium (an anticholinergic) to beta2-agonists may reduce the rate of hospital admissions in children and adults with moderate-to-severe asthma ...
WASHINGTON, Sept 23 (Reuters) - The blockbuster inhaled lung medication Spiriva, marketed by Pfizer Inc and Boehringer Ingelheim, raises the risk of heart attack, stroke and death from heart disease, ...
The Anticholinergic Drug Scale (ADS), developed by Boustani et al., was created to address the issue of anticholinergic burden. This term refers to the cumulative effect of using multiple medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results